{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T15:31:16Z","timestamp":1789140676325,"version":"build-2803163510"},"reference-count":64,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,6,5]],"date-time":"2025-06-05T00:00:00Z","timestamp":1749081600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Oncol."],"abstract":"<jats:p>Hepatic arterial infusion chemotherapy (HAIC) is one of the local treatment modalities employed for liver metastases. HAIC targets the delivery of chemotherapy drugs to the affected area by inserting a catheter into the tumor\u2019s blood-supplying artery. This approach not only enhances drug concentration within the tumor site, but also significantly reduces systemic side effects. Currently, there are various chemotherapeutic regimens available for HAIC in liver metastases; however, determining the optimal therapeutic agent remains elusive. This article provides a comprehensive review of HAIC dosing regimens and multimodal therapy for liver metastases originating from colorectal, breast, and gastric cancers. Meanwhile, this paper briefly outlines ongoing research on HAIC treatment for liver metastases associated with esophageal cancer, gastroenteropancreatic neuroendocrine tumors, and uveal melanoma.<\/jats:p>","DOI":"10.3389\/fonc.2025.1544061","type":"journal-article","created":{"date-parts":[[2025,6,5]],"date-time":"2025-06-05T00:12:59Z","timestamp":1749082379000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":4,"title":["Advances in hepatic arterial perfusion chemotherapy for hepatic metastases"],"prefix":"10.3389","volume":"15","author":[{"given":"Haodi","family":"Ou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaodong","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shulin","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guijie","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feng","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Song","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,6,5]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.21778","article-title":"Metastatic patterns in adenocarcinoma","volume":"106","author":"Hess","year":"2006","journal-title":"Cancer"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1016\/j.canep.2020.101760","article-title":"Epidemiology of liver metastases","volume":"67","author":"Horn","year":"2020","journal-title":"Cancer Epidemiol"},{"key":"B3","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1055\/s-0042-1758822","article-title":"Surgical and interventional management of liver metastasis","volume":"37","author":"Itenberg","year":"2022","journal-title":"Clinics Colon Rectal Surg"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2024.1464242","article-title":"Applications of image-guided locoregional transarterial chemotherapy in patients with inoperable colorectal cancer: a review","volume":"14","author":"Meng","year":"2024","journal-title":"Front Oncol"},{"key":"B5","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1007\/s00270-007-9189-0","article-title":"Hepatic arterial infusion chemotherapy through a port-catheter system as preoperative initial therapy in patients with advanced liver dysfunction due to synchronous and unresectable liver metastases from colorectal cancer","volume":"31","author":"Iguchi","year":"2008","journal-title":"Cardiovasc Intervent Radiol"},{"key":"B6","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.jimed.2023.03.001","article-title":"Optimal interventional treatment for liver cancer: HAIC, TACE or iTACE","volume":"6","author":"Ge","year":"2023","journal-title":"J Interv Med"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjsurg.2018.10.018","article-title":"Regional therapies for the treatment of primary and metastatic hepatic tumors: A disease-based review of techniques and critical appraisal of current evidence","volume":"217","author":"Johnson","year":"2019","journal-title":"Am J Surg"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1097\/01.RVI.0000242187.52057.95","article-title":"Pseudo-occlusion of the hepatic artery during hepatic arterial infusion chemotherapy","volume":"17","author":"Yamaura","year":"2006","journal-title":"J Vasc Interv Radiol"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.3816\/CCC.2010.n.044","article-title":"Hepatic arterial infusion of 5-fluorouracil for patients with liver metastases from colorectal cancer refractory to standard systemic chemotherapy: a multicenter, retrospective analysis","volume":"9","author":"Nishiofuku","year":"2010","journal-title":"Clin Colorectal Cancer"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1159\/000449349","article-title":"Recent advances in chemotherapy and surgery for colorectal liver metastases","volume":"6","author":"Passot","year":"2016","journal-title":"Liver Cancer"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1159\/000505520","article-title":"Hepatic arterial infusion chemotherapy of 5-fluorouracil for patients with unresectable liver metastases from colorectal cancer refractory to standard systemic chemotherapy: A multicenter retrospective study","volume":"98","author":"Sato","year":"2020","journal-title":"Oncology"},{"key":"B12","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1186\/s12957-015-0704-5","article-title":"Hepatic artery infusion therapy is effective for chemotherapy-resistant liver metastatic colorectal cancer","volume":"13","author":"Goi","year":"2015","journal-title":"World J Surg Oncol"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v23.i8.1406","article-title":"Hepatic artery infusion with raltitrexed or 5-fluorouracil for colorectal cancer liver metastasis","volume":"23","author":"Guo","year":"2017","journal-title":"World J Gastroenterol"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1245\/s10434-016-5418-6","article-title":"Hepatic arterial infusion in combination with modern systemic chemotherapy is associated with improved survival compared with modern systemic chemotherapy alone in patients with isolated unresectable colorectal liver metastases: A case-control study","volume":"24","author":"Dhir","year":"2017","journal-title":"Ann Surg Oncol"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1097\/01.RVI.0000153439.89142.1D","article-title":"Radiofrequency ablation therapy of remnant colorectal liver metastases after a course of hepatic arterial infusion chemotherapy","volume":"16","author":"Yamagami","year":"2005","journal-title":"J Vasc Interv Radiol"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(19940415)73:8<2042::aid-cncr2820730805>3.0.co;2-a","article-title":"Gastric mucosal injury after hepatic arterial infusion chemotherapy with floxuridine","volume":"73","author":"Doria","year":"1994","journal-title":"A Clin pathologic study. Cancer"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1245\/s10434-008-9882-5","article-title":"Results of preoperative hepatic arterial infusion chemotherapy in patients undergoing liver resection for colorectal liver metastases","volume":"15","author":"Pulitan\u00f2","year":"2008","journal-title":"Ann Surg Oncol"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1001\/jamasurg.2019.1694","article-title":"Role of hepatic artery infusion chemotherapy in treatment of initially unresectable colorectal liver metastases: A review","volume":"154","author":"Datta","year":"2019","journal-title":"JAMA Surg"},{"key":"B19","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1016\/j.hpb.2021.10.014","article-title":"Adjuvant intra-arterial chemotherapy for patients with resected colorectal liver metastases: a systematic review and meta-analysis","volume":"24","author":"Buisman","year":"2022","journal-title":"HPB (Oxford)"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(19860815)58:4<855::aid-cncr2820580409>3.0.co;2-6","article-title":"Liver pathology following hepatic arterial infusion chemotherapy","volume":"58","author":"Doria","year":"1986","journal-title":"Hepatic toxicity FUDR. Cancer"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1148\/radiology.161.2.2945226","article-title":"Causes of jaundice during hepatic artery infusion chemotherapy","volume":"161","author":"Anderson","year":"1986","journal-title":"Radiology"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2023.1231401","article-title":"Oxaliplatin-induced peripheral neurotoxicity in colorectal cancer patients: mechanisms, pharmacokinetics and strategies","volume":"14","author":"Cheng","year":"2023","journal-title":"Front Pharmacol"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1016\/j.hpb.2024.11.008","article-title":"Percutaneous hepatic artery infusion chemotherapy with oxaliplatin and fluoropyrimidines in treatment-resistant colorectal cancer patients with unresectable liver metastases: a retrospective cohort study","volume":"27","author":"Pat Fong","year":"2025","journal-title":"HPB (Oxford)"},{"key":"B24","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.ejca.2020.07.022","article-title":"Hepatic arterial infusion of oxaliplatin plus systemic chemotherapy and targeted therapy for unresectable colorectal liver metastases","volume":"138","author":"Boil\u00e8ve","year":"2020","journal-title":"Eur J Cancer"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejca.2023.113400","article-title":"Hepatic arterial oxaliplatin plus intravenous 5-fluorouracil and cetuximab for first-line treatment of colorectal liver metastases: A multicenter phase II trial","volume":"195","author":"Malka","year":"2023","journal-title":"Eur J Cancer"},{"key":"B26","doi-asserted-by":"publisher","first-page":"56","DOI":"10.2478\/jtim-2022-0004","article-title":"Predicting survival for hepatic arterial infusion chemotherapy of unresectable colorectal liver metastases: radiomics analysis of pretreatment computed tomography","volume":"10","author":"Liu","year":"2022","journal-title":"J Transl Int Med"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1007\/s00270-009-9532-8","article-title":"Early detection of therapeutic response to hepatic arterial infusion chemotherapy of liver metastases from colorectal cancer using diffusion-weighted MR imaging","volume":"32","author":"Marugami","year":"2009","journal-title":"Cardiovasc Intervent Radiol"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1016\/s0002-9610(02)01204-7","article-title":"An attempt to clarify indications for hepatectomy for liver metastases from breast cancer","volume":"185","author":"Elias","year":"2003","journal-title":"Am J Surg"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1159\/000517854","article-title":"Successful treatment with hepatic arterial infusion chemotherapy in a breast cancer patient with multiple liver metastases who declined systemic therapy","volume":"14","author":"Masuda","year":"2021","journal-title":"Case Rep Oncol"},{"key":"B30","article-title":"A case of multiple liver metastases from breast cancer in which we confirmed disappearance of cancer cells after hepatic resection following hepatic arterial infusion chemotherapy","volume":"29","author":"Fujito","year":"2002","journal-title":"Gan To Kagaku Ryoho"},{"key":"B31","first-page":"395","article-title":"Endocrine ablation and hepatic artery infusion in the treatment of metastases to the liver from carcinoma of the breast","volume":"155","author":"Peetz","year":"1982","journal-title":"Surg Gynecol Obstet"},{"key":"B32","article-title":"The features of liver metastasis of breast cancer on imaging and its response to arterial infusion chemotherapy","volume":"13","author":"Kakuta","year":"1986","journal-title":"Gan To Kagaku Ryoho"},{"key":"B33","article-title":"Changes in CT findings in patients with liver metastases of breast cancer during effective intra-arterial infusion","volume":"15","author":"Miyake","year":"1988","journal-title":"Gan To Kagaku Ryoho"},{"key":"B34","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1002\/jso.2930550108","article-title":"The regional treatment of liver metastases from breast cancer","volume":"55","author":"Schneebaum","year":"1994","journal-title":"J Surg Oncol"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1007\/s00432-017-2462-y","article-title":"Hepatic arterial infusion chemotherapy for extensive liver metastases of breast cancer: efficacy, safety and prognostic parameters","volume":"143","author":"Tewes","year":"2017","journal-title":"J Cancer Res Clin Oncol"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.21873\/invivo.11771","article-title":"Hepatic arterial infusion chemotherapy for metastatic breast cancer patients with resistance to standard systemic chemotherapies","volume":"34","author":"Furuta","year":"2020","journal-title":"In Vivo"},{"key":"B37","article-title":"Liver metastases from breast cancer 14 years after radical mastectomy; successful treatment with hepatic arterial infusion chemotherapy and systemic endocrine therapy\u2013a case report","volume":"24","author":"Onogawa","year":"1997","journal-title":"Gan To Kagaku Ryoho"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.21873\/invivo.11425","article-title":"Hepatic arterial infusion chemotherapy is a feasible treatment option for breast cancer with liver-predominant metastatic disease","volume":"32","author":"Hsiao","year":"2018","journal-title":"In Vivo"},{"key":"B39","article-title":"A case of hepatic arterial infusion chemotherapy with docetaxel for liver metastasis from breast cancer","volume":"26","author":"Kim","year":"1999","journal-title":"Gan To Kagaku Ryoho"},{"key":"B40","article-title":"A case report of liver metastasis of breast cancer successfully treated by hepatic arterial infusion of docetaxel and systemic administration of nab-paclitaxel","volume":"39","author":"Satoh","year":"2012","journal-title":"Gan To Kagaku Ryoho"},{"key":"B41","article-title":"A case of liver metastases of breast cancer successfully treated by combination chemotherapy using hepatic arterial infusion of docetaxel and systemic administration of trastuzumab","volume":"31","author":"Hashimoto","year":"2004","journal-title":"Gan To Kagaku Ryoho"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1177\/15330338211051552","article-title":"Hepatic artery infusion pump combined with systemic chemotherapy for patients with liver metastases from breast carcinoma","volume":"20","author":"Shi","year":"2021","journal-title":"Technol Cancer Res Treat"},{"key":"B43","article-title":"A case of recurrent breast cancer successfully treated with capecitabine monotherapy","volume":"32","author":"Mitsuyama","year":"2005","journal-title":"Gan To Kagaku Ryoho"},{"key":"B44","article-title":"A case of liver metastasis of breast cancer successfully treated with paclitaxel infusion into the hepatic artery: an attempt of once weekly regimen","volume":"29","author":"Iwamoto","year":"2002","journal-title":"Gan To Kagaku Ryoho"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1097\/JS9.0000000000001068","article-title":"A bibliometric analysis of gastric cancer liver metastases: advances in mechanisms of occurrence and treatment options","volume":"110","author":"Wang","year":"2024","journal-title":"Int J Surg"},{"key":"B46","article-title":"Clinical modalities for management of gastric cancer hepatic metastasis","volume":"8","author":"Tao","year":"2015","journal-title":"Int J Clin Exp Med"},{"key":"B47","article-title":"A long-term survival case of gastric cancer with liver metastases treated by hepatic arterial infusion chemotherapy","volume":"35","author":"Masuzawa","year":"2008","journal-title":"Gan To Kagaku Ryoho"},{"key":"B48","article-title":"Evaluation of arterial infusion chemotherapy for liver metastasis from gastric cancer","volume":"30","author":"Takeno","year":"2003","journal-title":"Gan To Kagaku Ryoho"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1186\/1477-7819-5-70","article-title":"Treatment of multiple liver metastasis from gastric carcinoma","volume":"5","author":"Ojima","year":"2007","journal-title":"World J Surg Oncol"},{"key":"B50","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1186\/s12957-015-0686-3","article-title":"Long-term survival with complete remission after hepatic arterial infusion chemotherapy for liver metastasis from gastric cancer: a case report","volume":"13","author":"Toyokawa","year":"2015","journal-title":"World J Surg Oncol"},{"key":"B51","article-title":"Pre-operative treatment with transcatheter arterial chemoembolization (TACE) and hepatic arterial infusion (HAI) for liver metastasis from gastric cancer\u2013A case report","volume":"42","author":"Tanigawa","year":"2015","journal-title":"Gan To Kagaku Ryoho"},{"key":"B52","article-title":"Efficacy of combined local therapy especially with hepatic arterial infusion for liver metastasis from gastric cancer","volume":"40","author":"Hasuike","year":"2013","journal-title":"Gan To Kagaku Ryoho"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.1155\/2018\/5402313","article-title":"The effectiveness of hepatic arterial infusion chemotherapy with 5-fluorouracil\/cisplatin and systemic chemotherapy with ramucirumab in alpha-fetoprotein-producing gastric cancer with multiple liver metastases","volume":"2018","author":"Doi","year":"2018","journal-title":"Case Rep Oncol Med"},{"key":"B54","article-title":"A case of advanced gastric cancer with multiple liver metastases responding completely to hepatic arterial infusion and systemic chemotherapies","volume":"30","author":"Imamura","year":"2003","journal-title":"Gan To Kagaku Ryoho"},{"key":"B55","article-title":"A case of AFP producing early gastric cancer successfully treated with small dose CDDP and 5-FU (PF) therapy","volume":"28","author":"Moritani","year":"2001","journal-title":"Gan To Kagaku Ryoho"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.3892\/or.17.5.1077","article-title":"A successful treatment for metastatic liver tumors from endocrine carcinoma of the stomach","volume":"17","author":"Nishimura","year":"2007","journal-title":"Oncol Rep"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.1159\/000012034","article-title":"Phase II study of combined administration of 5-fluorouracil, epirubicin and mitomycin-C by hepatic artery infusion in patients with liver metastases of gastric cancer","volume":"57","author":"Kumada","year":"1999","journal-title":"Oncology"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.1177\/0284185115603247","article-title":"Hepatic arterial infusion chemotherapy using fluorouracil, epirubicin, and mitomycin C for patients with liver metastases from gastric cancer after treatment failure of systemic S-1 plus cisplatin","volume":"57","author":"Seki","year":"2016","journal-title":"Acta Radiol"},{"key":"B59","article-title":"Percutaneous ethanol injection therapy with hepatic arterial infusion chemotherapy for liver metastases from gastric cancer","volume":"26","author":"Katayanagi","year":"1999","journal-title":"Gan To Kagaku Ryoho"},{"key":"B60","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/j.ijsu.2017.08.578","article-title":"Adjuvant hepatic artery infusion chemotherapy after hemihepatectomy for gastric cancer liver metastases","volume":"46","author":"Fukami","year":"2017","journal-title":"Int J Surg"},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2023.1143617","article-title":"HAIC as a potential therapy for esophageal cancer patients with liver metastasis: a retrospective cohort study","volume":"10","author":"Dong","year":"2023","journal-title":"Front Med (Lausanne)"},{"key":"B62","doi-asserted-by":"publisher","DOI":"10.1053\/j.seminoncol.2018.07.002","article-title":"Metastatic neuroendocrine tumors of the gastrointestinal tract and pancreas: A surgeon\u2019s plea to centering attention on the liver","volume":"45","author":"Keutgen","year":"2018","journal-title":"Semin Oncol"},{"key":"B63","doi-asserted-by":"publisher","DOI":"10.21147\/j.issn.1000-9604.2017.06.13","article-title":"Retrospective analysis of interventional treatment of hepatic metastasis from gastroenteropancreatic neuroendocrine tumors","volume":"29","author":"Liu","year":"2017","journal-title":"Chin J Cancer Res"},{"key":"B64","doi-asserted-by":"publisher","DOI":"10.1007\/s00270-022-03130-1","article-title":"Radiation dose aspects of hepatic artery infusion chemotherapy in uveal melanoma patients with liver metastases","volume":"45","author":"Zensen","year":"2022","journal-title":"Cardiovasc Intervent Radiol"}],"container-title":["Frontiers in Oncology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2025.1544061\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,5]],"date-time":"2025-06-05T00:13:02Z","timestamp":1749082382000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2025.1544061\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,5]]},"references-count":64,"alternative-id":["10.3389\/fonc.2025.1544061"],"URL":"https:\/\/doi.org\/10.3389\/fonc.2025.1544061","relation":{},"ISSN":["2234-943X"],"issn-type":[{"value":"2234-943X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,5]]},"article-number":"1544061"}}